Bajaj Healthcare Ltd - Stock Valuation and Financial Performance

BSE: 539872 | NSE: BAJAJHCARE | Pharmaceuticals & Drugs | Small Cap

Bajaj Healthcare Share Price

317.60 -3.30 -1.03%
as on 19-Apr'24 13:42

DeciZen - make an informed investing decision on Bajaj Healthcare

Overall Rating
Bole Toh

1. Quality

2. Valuation

Fair

3. Price Trend

Semi Strong

Bajaj Healthcare stock performance -

mw4me loader
P/E Ratio (SA):
41.65
Market Cap:
885.6 Cr.
52-wk low:
245.1
52-wk high:
511

Is Bajaj Healthcare Ltd an attractive stock to invest in?

1. Is Bajaj Healthcare Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Bajaj Healthcare Ltd is a average quality company.

2. Is Bajaj Healthcare Ltd undervalued or overvalued?

The key valuation ratios of Bajaj Healthcare Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Bajaj Healthcare Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Bajaj Healthcare Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Bajaj Healthcare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bajaj Healthcare Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 8.4%10.5%8.7%7%10.3%11.6%12.8%24.3%16%8.8%-
Value Creation
Index
-0.4-0.3-0.4-0.5-0.3-0.2-0.10.70.1-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 186197200207290325410657680673498
Sales YoY Gr.-6.2%1.5%3.5%39.7%12.3%26.2%60.2%3.5%-1%-
Adj EPS 1.22.83.22.356.59.42926.4167.7
YoY Gr.-132.8%12.7%-28.1%118.7%28.8%44.9%208.7%-9.1%-39.5%-
BVPS (₹) 1113.817.235.926.432.264.593.6119133.2116.6
Adj Net
Profit
3.37.78.76.413.917.925.98072.74421
Cash Flow from Ops. 17.327.925.122.116.625.220.643.60.7-22.3-
Debt/CF from Ops. 4.12.53.23.45.23.24.44.2374.3-18.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 15.4%18.4%18%-1%
Adj EPS 33.1%26%19.3%-39.5%
BVPS31.9%38.3%27.4%11.9%
Share Price - 24.7% 13.6% -1.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
10.913.510.26.813.114.816.936.724.812.76.2
Op. Profit
Mgn %
11.514.715.514.913.61412.520.817.716.215.9
Net Profit
Mgn %
1.83.94.33.14.85.56.312.210.76.54.3
Debt to
Equity
2.31.81.80.81.20.90.50.70.81.1-
Working Cap
Days
139137128133124128131115173242178
Cash Conv.
Cycle
70666769586366498915425

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 17.98%

Net Profit is growing at healthy rate in last 3 years 19.32%

Return on Equity has declined versus last 3 years average to 6.20%

Debt to equity has increased versus last 3 years average to 1.13

Sales growth is not so good in last 4 quarters at -24.23%

Latest Financials - Bajaj Healthcare Ltd.

Standalone Consolidated
TTM EPS (₹) 7.7 -
TTM Sales (₹ Cr.) 498 -
BVPS (₹.) 116.6 -
Reserves (₹ Cr.) 308 -
P/BV 2.75 -
PE 41.65 -
From the Market
52 Week Low / High (₹) 245.05 / 511.00
All Time Low / High (₹) 42.50 / 511.90
Market Cap (₹ Cr.) 886
Equity (₹ Cr.) 13.8
Face Value (₹) 5
Industry PE 47.6

Management X-Ray of Bajaj Healthcare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Bajaj Healthcare

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales186197200207290325410657680673
Operating Expenses 166168170176250282362521561566
Manufacturing Costs33363737414753899293
Material Costs113111106111178197263378406399
Employee Cost 12141720222528354148
Other Costs 8710991418192227
Operating Profit 20293031394348136119107
Operating Profit Margin (%) 10.5%14.6%15.0%14.9%13.6%13.2%11.8%20.8%17.5%15.9%
Other Income 0002217712
Interest 788888781323
Depreciation 99911111112161827
Exceptional Items 0000000000
Profit Before Tax 31213142324361199058
Tax 15567811361815
Profit After Tax 2888151625837143
PAT Margin (%) 1.1%3.8%4.1%3.8%5.2%5.0%6.2%12.7%10.5%6.4%
Adjusted EPS (₹)0.82.83.02.85.55.99.130.125.915.6
Dividend Payout Ratio (%)0%0%0%0%5%0%0%5%6%6%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 31828999114129178258328368
Share Capital 44777714141414
Reserves 28788292107122164245315354
Minority Interest0000000000
Debt63607466767282168243383
Long Term Debt15223127211724806694
Short Term Debt4937423955555888176289
Trade Payables312316194330576910585
Others Liabilities 20243035353526304566
Total Liabilities 145189209219268267343526721901

Fixed Assets

Gross Block100162191200210222268329402525
Accumulated Depreciation455362728394106121132159
Net Fixed Assets56108130128127128162208270366
CWIP 3110215575222
Investments 0000005000
Inventories2318201734303997159209
Trade Receivables5552435380789899185227
Cash Equivalents 110188414218
Others Assets791521172128505460
Total Assets 145189209219268267343526721901

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 17282522172521441-22
PBT 31213142324361199058
Adjustment 16171719192016243156
Changes in Working Capital -2-0-0-6-19-6-22-64-111-125
Tax Paid 0-1-5-5-6-13-9-36-10-12
Cash Flow From Investing Activity -9-17-31-8-12-13-28-109-75-93
Capex -11-18-30-10-10-15-18-62-79-123
Net Investments 000000-5500
Others 2201-22-4-52430
Cash Flow From Financing Activity -8-115-132-1337562131
Net Proceeds from Shares 0003000000
Net Proceeds from Borrowing -589-5-5-4656-1245
Interest Paid -7-8-8-8-8-8-6-8-13-23
Dividend Paid 00000-10-2-1-4
Others 4-113-315043088113
Net Cash Flow 100070-410-1216
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)7.3122.3819.610.7717.6820.1818.9238.0924.3312.36
ROCE (%)10.6719.161814.5218.2519.7519.4735.912011.88
Asset Turnover Ratio1.491.311.121.081.341.381.341.511.090.83
PAT to CFO Conversion(x)8.53.53.132.751.131.560.840.530.01-0.51
Working Capital Days
Receivable Days888977767478795576112
Inventory Days353531292831313869100
Payable Days81886757646861617887

Bajaj Healthcare Ltd Stock News

Bajaj Healthcare Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Bajaj Healthcare on 19-Apr-2024 13:42 is ₹317.6.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 19-Apr-2024 13:42 the market cap of Bajaj Healthcare stood at ₹885.6.
The latest P/E ratio of Bajaj Healthcare as of 19-Apr-2024 13:42 is 41.65.
The latest P/B ratio of Bajaj Healthcare as of 19-Apr-2024 13:42 is 2.75.
The 52-week high of Bajaj Healthcare is ₹511.0 and the 52-week low is ₹245.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bajaj Healthcare is ₹498.0 ( Cr.) .

About Bajaj Healthcare Ltd

The company was incorporated as Bajaj Healthcare Private Limited on July 15, 1993 under the Companies Act, 1956, with the Registrar of Companies, Mumbai bearing Registration Number - 072892. The status of the company was changed to a public limited company and the name of the company was changed to Bajaj Healthcare Limited by a special resolution passed on March 15, 2005. A fresh certificate of incorporation consequent to the change of name was granted to the company on March 31, 2005, by the Registrar of Companies, Mumbai. The company began its operations in the year 1993 with an API manufacturing unit in Tarapur, near Mumbai. Over the years it has expanded its scale and scope of operations and currently it operates five manufacturing units for manufacture of APIs, Intermediates and Formulations.

The company’s present product portfolio consists of various APIs in the therapeutic categories of Neutraceutical (Amino Acids), Vitamins, Anti-Convulsants, Bactericidal & Bacteriostatic, Diuretic & Vasodilator, Mineral & Nutritional supplements, Bronchodilater / Anti-asthmatic and Nootropics. The company’s Formulations unit manufactures tablets, capsules and sachets for its own brands as well as under Loan License (job work) for other pharmaceutical companies. Currently, the company manufactures formulations for GlaxoSmithKline Pharmaceuticals (GSK) and USV (USV) on a Loan License basis. The formulations manufactured for its own brands are manufactured and marketed under a separate division of Bajaj Medicare and it also has marketing tie-up with TTK Healthcare. The FDFs manufactured by it covers various therapeutic segments like Antibiotics, Anti-Arrhythmia, Anti-Convulsants, Anti-Diabetes, Anti-Platelets, NSAIDs, Vitamins & its Derivatives, Anti-Hypertensive, Anti-Bacterial, Anti-Malarial, Cholinesterase Inhibitors, etc.

With the combined production of its API facilities and that of its Formulation unit, the company’s product portfolio consists of APIs and FDFs which shall be marketed in domestic and international markets as branded generics. Presently it is supplying its APIs and FDFs both domestically and exporting to various countries in regions like, Europe, USA, Australia, Africa, South America, etc. With its long standing operations and quality products, the company has built a strong relationship with its customers for both APIs and FDFs. Some of its major clients include nationally and internationally known pharmaceutical companies like Glaxo Smithkline Consumer Healthcare, Ava Inc., Abbott Healthcare, Piramal Enterprises, Pfizer, Colgate Palmolive India, Lupin and Intas Pharmaceuticals to name a few.

Business area of the company

Bajaj Healthcare is a pharmaceutical company with manufacturing and marketing capabilities in Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosage Formulations (FDFs) with focus on Vitamins, Amino Acids, Anti-Convulsants and Finished Dosage Forms (FDFs) caters to various therapeutic segments.

Major events

  • 1993-1994: Incorporated under Companies Act, 1956 as Bajaj Healthcare Private Limited by setting up plant at Tarapur.
  • 1996-1997: First Export Sale.
  • 2004-2005: Changed the status of the company from Private to Public i.e. to Bajaj Healthcare Limited.
  • 2005-2006: Purchase and Set-up a new facility at Salvi, Vadodara.
  • 2005-2006: Set up Corporate Office in Masjid Bunder.
  • 2006-2007: Purchase addition Plot N- 128 at Tarapur.
  • 2006-2007: Issued 20,00,000, Non- Cumulative Preference Shares of Rs 10 each.
  • 2006-2007: Major Term loan of Rs 863.00 lakhs was sanction and its total indebtedness reached to Rs 2,265 Lakh.
  • 2007-2008 Purchase and Set-up a new facility at Manjusar, Vadodara.
  • 2007-2008 Increase in Capacity of its major products like; 100% Vitamin C and its derivatives and 50% in Choline Bitartrate, etc.
  • 2009-2010: Launched own brands under Manjusar/ Medicare.
  • 2013-2014: Purchase and Set-up a new facility at Panoli, Ankleshwar.
  • 2013-2014: First GVK Agreement.
  • 2013-2014: First USV Agreement.
  • 2014-2015: Purchase and Set-up a Second facility at Tarapur, Maharashtra.
  • 2015-2016: Acquisition of premises for new Corporate Office in Thane and set-up of the same.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.